Skip to Main Content

This column is from Trendlines, a business newsletter that covers the forces shaping the economy in Boston and beyond. If you’d like to receive it via email on Mondays, Wednesdays, and Fridays, sign up here.

It’s Boston’s biggest divorce since Gisele and Tom split, but this one is epically acrimonious and has real-life repercussions for the region’s hospital industry and its patients.


The news: Dana-Farber Cancer Institute said on Thursday that it would end its long and nationally acclaimed adult oncology partnership with Brigham and Women’s Hospital. Instead, it plans to open a new freestanding cancer hospital with Beth Israel Deaconess Medical Center where the Joslin Diabetes Center now stands in the Longwood Medical Area. (Joslin will relocate.)

Get unlimited access to award-winning journalism and exclusive events.


Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!

To submit a correction request, please visit our Contact Us page.